Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit
- 196 Downloads
Background Problems related to pharmacotherapy are common in patients admitted to the paediatric intensive care unit (PICU) and are associated with increased healthcare costs. Data on the impact of clinical pharmacist interventions to prevent pharmacotherapy-related problems and to minimize costs in the PICU are limited. Objectives To evaluate the number and type of clinical pharmacist interventions in the PICU and to determine cost savings associated with them. Setting a ten bed PICU of a tertiary-care university hospital in Brazil. Method This was a prospective, observational study conducted over 1-year. The Failure Mode and Effects Analysis (FMEA) tool was applied at the beginning of the study to assess drug-related risks in the PICU and to guide clinical pharmacist interventions. Main outcome measure Number and type of clinical pharmacist interventions and healthcare-related costs. Results One hundred sixty-two children were followed-up by the clinical pharmacist and 1586 prescriptions were evaluated; pharmacotherapy-related problems were identified in 12.4% of them. Sixteen of 75 failure modes identified by FMEA were potentially reduced by the clinical pharmacist interventions. There were 197 interventions with a cost saving of R$ 15,118.73 (US$ 4828.00). Clinical pharmacist interventions were related to drug interaction and therapeutic monitoring (34.5%), drug selection (22.3%), dosing and frequency (16.8%), prescription (13.2%) and administration (13.2%). Ninety-seven per cent of the clinical pharmacist interventions were accepted by the medical team. The interventions with larger cost savings were related to administration (39%). Conclusion The clinical pharmacist interventions minimized the risks of pharmacotherapy-related problems and contributed to the reduction of costs associated with medical prescription.
KeywordsBrazil Clinical pharmacy DRPs Healthcare costs Paediatric intensive care unit Pharmacotherapy-related problems
We thank all the members of the FMEA team for their participation in this study.
This study did not receive any specific funding support.
Conflicts of interest
The authors have no conflicts of interest to disclose.
- 1.Pharmaceutical Care Network Europe (PCNE). PCNE classification of drug-related problems (V6.2). 2010. http://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf. Accessed on 1 June 2015.
- 5.Ministério da Saúde (BR). Agência Nacional de Vigilância Sanitária. Resolução RDC/ANVISA: n° 7, de 24 de fevereiro de 2010. Diário Oficial da República Federativa do Brasil, Brasília, DF, 25 fev 2010. [Ministry of Health (Brazil). National Health Surveillance Agency. Resolution RDC/ANVISA: number 7, from February 24, 2010. Official Gazette of the Federative Republic of Brazil, Brasilia, Federal District, February 25, 2010].Google Scholar
- 11.Manrique-Rodríguez S, Sánchez-Galindo AC, López-Herce J, Calleja-Hernández MÁ, Iglesias-Peinado I, Carrillo-Álvarez A, et al. Risks in the implementation and use of smart pumps in a pediatric intensive care unit: application of the failure mode and effects analysis. Int J Technol Assess Health Care. 2014;30(2):210–7.CrossRefPubMedGoogle Scholar
- 12.Joint Commission on Accreditation of Healthcare Organization (JCAHO). Hospital accreditation standards: standards, intents: HAS. Chicago: Joint Commission; 2005.Google Scholar
- 15.Trissel LA. Handbook on injectable drugs. 15th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2009.Google Scholar
- 16.Micromedex® 2.0, (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. http://www-micromedexsolutions-com.ez67.periodicos.capes.gov.br/. Accessed between July 2015 and June 2016.
- 17.UpToDate Inc. http://www.uptodate.com. Accessed between July 2015 and June 2016.
- 18.Institute for Safe Medication Practices ISMP list of high-alert medications in acute care settings. 2014. www.ismp.org/tools/institutionalhighAlert.asp. Accessed between July 2015 and June 2016.